Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse - PubMed (original) (raw)
Comparative Study
Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse
E M Ingram et al. J Neurochem. 2001 Nov.
Free article
Abstract
There is extensive experimental evidence indicating a crucial role for glutamate in epileptogenesis and epileptic activity. The glial glutamate transporters GLT1 and GLAST are proposed to account for the majority of extracellular glutamate re-uptake. In the present study, polyclonal antibodies specific to GLT1 and GLAST were generated and characterized, revealing distribution patterns for the two transporters confirming those previously reported. In situ hybridization and immunoblotting were then used to compare levels of these two transporters in the parietal cortex and hippocampus of unstimulated and stimulated EL mice with DDY control mice. Additionally, HPLC determined tissue glutamate concentrations in the same regions of these animals. These experiments revealed reductions in GLT1 mRNA and protein in the parietal cortex of unstimulated and stimulated EL mice compared with DDY controls, accompanied by an increase in tissue glutamate concentration in the stimulated EL mice group. GLT1 mRNA was also reduced in the CA3 hippocampal subfield of both unstimulated and stimulated EL mice. GLAST protein was reduced in the hippocampus of the stimulated EL mice group, while no changes in GLAST mRNA or protein were detected in the parietal cortex of EL mice when compared with DDY controls. The glial glutamate transporter down-regulation reported here may play a role in seizure initiation, spread and maintenance in the EL mouse.
Similar articles
- Developmental expression of glutamate transporters and glutamate dehydrogenase in astrocytes of the postnatal rat hippocampus.
Kugler P, Schleyer V. Kugler P, et al. Hippocampus. 2004;14(8):975-85. doi: 10.1002/hipo.20015. Hippocampus. 2004. PMID: 15390174 - Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy.
Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH, van Veelen CW, van Rijen PC, van Nieuwenhuizen O, Gispen WH, de Graan PN. Proper EA, et al. Brain. 2002 Jan;125(Pt 1):32-43. doi: 10.1093/brain/awf001. Brain. 2002. PMID: 11834591 - Molecular regulation of antioxidant ability in the hippocampus of EL mice.
Takaki M, Ueda Y, Doi T, Nagatomo K, Murashima YL, Kannan H. Takaki M, et al. Brain Res. 2008 Sep 4;1228:1-5. doi: 10.1016/j.brainres.2008.06.041. Epub 2008 Jun 21. Brain Res. 2008. PMID: 18621028 - [Role of glutamate transporters in the pathophysiology of major mental illnesses].
Tanaka K. Tanaka K. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Aug;29(4):161-4. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009. PMID: 19764483 Review. Japanese. - Ictogenesis and epileptogenesis in EL mice.
Murashima YL, Yoshii M, Suzuki J. Murashima YL, et al. Epilepsia. 2002;43 Suppl 5:130-5. doi: 10.1046/j.1528-1157.43.s.5.35.x. Epilepsia. 2002. PMID: 12121307 Review.
Cited by
- The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.
Sheldon AL, Robinson MB. Sheldon AL, et al. Neurochem Int. 2007 Nov-Dec;51(6-7):333-55. doi: 10.1016/j.neuint.2007.03.012. Epub 2007 Apr 19. Neurochem Int. 2007. PMID: 17517448 Free PMC article. Review. - Neurological diseases as primary gliopathies: a reassessment of neurocentrism.
Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M. Verkhratsky A, et al. ASN Neuro. 2012 Apr 5;4(3):e00082. doi: 10.1042/AN20120010. ASN Neuro. 2012. PMID: 22339481 Free PMC article. Review. - Mitochondria, oxidative stress, and temporal lobe epilepsy.
Waldbaum S, Patel M. Waldbaum S, et al. Epilepsy Res. 2010 Jan;88(1):23-45. doi: 10.1016/j.eplepsyres.2009.09.020. Epub 2009 Oct 21. Epilepsy Res. 2010. PMID: 19850449 Free PMC article. Review. - Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
Zeng LH, Bero AW, Zhang B, Holtzman DM, Wong M. Zeng LH, et al. Neurobiol Dis. 2010 Mar;37(3):764-71. doi: 10.1016/j.nbd.2009.12.020. Epub 2010 Jan 4. Neurobiol Dis. 2010. PMID: 20045054 Free PMC article. - Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion.
Wu X, Kihara T, Hongo H, Akaike A, Niidome T, Sugimoto H. Wu X, et al. Br J Pharmacol. 2010 Sep;161(1):33-50. doi: 10.1111/j.1476-5381.2010.00840.x. Br J Pharmacol. 2010. PMID: 20718738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous